David Bryant

1.0k total citations
27 papers, 729 citations indexed

About

David Bryant is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, David Bryant has authored 27 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Physiology. Recurrent topics in David Bryant's work include Respiratory and Cough-Related Research (5 papers), Asthma and respiratory diseases (5 papers) and Cancer Genomics and Diagnostics (4 papers). David Bryant is often cited by papers focused on Respiratory and Cough-Related Research (5 papers), Asthma and respiratory diseases (5 papers) and Cancer Genomics and Diagnostics (4 papers). David Bryant collaborates with scholars based in United States, Australia and Bosnia and Herzegovina. David Bryant's co-authors include Sara Milchgrub, Carmen Behrens, Ignacio I. Wistuba, John D. Minna, Adi F. Gazdar, Jaclyn Y. Hung, Nicholas J. Vogelzang, Zoran Gatalica, Sherri Z. Millis and Peter A. W. Rogers and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and CHEST Journal.

In The Last Decade

David Bryant

27 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Bryant United States 10 386 217 213 151 124 27 729
Seung Taik Kim South Korea 15 253 0.7× 182 0.8× 125 0.6× 131 0.9× 103 0.8× 29 588
Jane E. Parr United States 9 526 1.4× 59 0.3× 136 0.6× 57 0.4× 74 0.6× 10 702
Grzegorz Szewczyk Poland 16 311 0.8× 97 0.4× 103 0.5× 50 0.3× 85 0.7× 61 917
Hee Jung Son South Korea 13 145 0.4× 256 1.2× 322 1.5× 209 1.4× 134 1.1× 28 756
Skaidrius Miliauskas Lithuania 14 498 1.3× 439 2.0× 189 0.9× 94 0.6× 78 0.6× 67 1.0k
Kenji Nishii Japan 10 192 0.5× 183 0.8× 200 0.9× 93 0.6× 40 0.3× 30 572
Tomáš Rohan Czechia 14 108 0.3× 282 1.3× 163 0.8× 110 0.7× 211 1.7× 45 687
Andrea Zitella Italy 17 156 0.4× 72 0.3× 212 1.0× 114 0.8× 262 2.1× 36 636
Anne‐Marie Langevin United States 12 133 0.3× 113 0.5× 103 0.5× 64 0.4× 68 0.5× 29 518

Countries citing papers authored by David Bryant

Since Specialization
Citations

This map shows the geographic impact of David Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bryant more than expected).

Fields of papers citing papers by David Bryant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bryant. The network helps show where David Bryant may publish in the future.

Co-authorship network of co-authors of David Bryant

This figure shows the co-authorship network connecting the top 25 collaborators of David Bryant. A scholar is included among the top collaborators of David Bryant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Bryant. David Bryant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ribeiro, Jennifer R., Todd Maney, Stephanie Rock, et al.. (2025). GPSai: A Clinically Validated AI Tool for Tissue of Origin Prediction during Routine Tumor Profiling. Cancer Research Communications. 5(9). 1477–1489. 1 indexed citations
2.
Wang, Hao, et al.. (2025). Evaluating fairness of machine learning prediction of prolonged wait times in Emergency Department with Interpretable eXtreme gradient boosting. PLOS Digital Health. 4(3). e0000751–e0000751. 1 indexed citations
3.
Ali‐Fehmi, Rouba, Matthew J. Oberley, Thomas J. Herzog, et al.. (2023). Analysis of concordance between microsatellite instability by next generation sequencing (NGS-MSI) and mismatch repair deficiency by immunohistochemistry (IHC-MMR) in >28,000 colorectal tumors.. Journal of Clinical Oncology. 41(4_suppl). 30–30. 1 indexed citations
4.
Hu, Jennifer J., James J. Urbanic, L. D. Case, et al.. (2018). Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer Population. Journal of Clinical Oncology. 36(24). 2473–2482. 38 indexed citations
5.
Joseph, Richard W., Sherri Z. Millis, Estrella M. Carballido, et al.. (2015). PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation. Cancer Immunology Research. 3(12). 1303–1307. 131 indexed citations
6.
Ho, Thai H., Sherri Z. Millis, David Bryant, et al.. (2015). Molecular analysis of sarcomatoid renal cell carcinoma (sRCC).. Journal of Clinical Oncology. 33(15_suppl). 4556–4556. 1 indexed citations
7.
Shaw, Edward G., Lingyi Lu, David Bryant, et al.. (2015). Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Neuro-Oncology. 17(10). 1393–1401. 50 indexed citations
8.
Weaver, Kathryn E., James J. Urbanic, Doug Case, et al.. (2015). Preliminary efficacy of an enhanced quitline smoking cessation intervention for cancer patients.. Journal of Clinical Oncology. 33(15_suppl). e20671–e20671. 3 indexed citations
9.
Millis, Sherri Z., David Bryant, Gargi D. Basu, et al.. (2014). Molecular Profiling of Infiltrating Urothelial Carcinoma of Bladder and Nonbladder Origin. Clinical Genitourinary Cancer. 13(1). e37–e49. 53 indexed citations
10.
Millis, Sherri Z., David Bryant, Gargi D. Basu, et al.. (2014). Molecular profiling of infiltrating urothelial carcinoma of the bladder.. Journal of Clinical Oncology. 32(4_suppl). 311–311. 1 indexed citations
11.
Wistuba, Ignacio I., Carmen Behrens, Sara Milchgrub, et al.. (1999). Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene. 18(3). 643–650. 252 indexed citations
12.
Bryant, David & Peter A. W. Rogers. (1992). Effects of Ipratropium Bromide Nebulizer Solution with and without Preservatives in the Treatment of Acute and Stable Asthma. CHEST Journal. 102(3). 742–747. 21 indexed citations
13.
Bittoun, Renée, Michael McMahon, & David Bryant. (1991). Smoking in hospitalised patients. Addictive Behaviors. 16(1-2). 79–81. 11 indexed citations
14.
Bryant, David & Peter A. W. Rogers. (1991). Allergic Alveolitis Due To Wood-Rot Fungi. Allergy and Asthma Proceedings. 12(2). 89–94. 16 indexed citations
15.
Cairns, David A., William M. Burke, David Bryant, et al.. (1991). Interstitial Lung Disease Associated with Connective Tissue Diseases: The Use of Statistical Structure Analysis in Model Development. American Review of Respiratory Disease. 143(6). 1235–1240. 6 indexed citations
16.
Chapman, Kenneth R., David Bryant, G. E. Marlin, et al.. (1989). A Placebo-controlled Dose-Response Study of Enprofylline in the Maintenance Therapy of Asthma. American Review of Respiratory Disease. 139(3). 688–693. 8 indexed citations
17.
Cooper, David A., Debbie Marriott, Jock Harkness, & David Bryant. (1988). The acquired immunodeficiency syndrome and tuberculosis. The Medical Journal of Australia. 149(11-12). 714–715. 3 indexed citations
18.
Ruffin, Richard E., David Bryant, G. E. Marlin, et al.. (1988). Comparison of the Effects of Nebulized Terbutaline with Intravenous Enprofylline in Patients with Acute Asthma. CHEST Journal. 93(3). 510–514. 6 indexed citations
19.
Bryant, David. (1985). Nebulized Ipratropium Bromide in the Treatment of Acute Asthma. CHEST Journal. 88(1). 24–29. 68 indexed citations
20.
Burns, M. W., Lorraine Devitt, & David Bryant. (1973). WHY DO SPUTUM CULTURES FAIL TO YIELD PATHOGENS?. The Medical Journal of Australia. 2(16). 768–769. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seung Taik Kim Breakdown of academic impact, for papers by Jane E. Parr Breakdown of academic impact, for papers by Grzegorz Szewczyk Breakdown of academic impact, for papers by Hee Jung Son Breakdown of academic impact, for papers by Skaidrius Miliauskas Breakdown of academic impact, for papers by Kenji Nishii Breakdown of academic impact, for papers by Tomáš Rohan Breakdown of academic impact, for papers by Andrea Zitella Breakdown of academic impact, for papers by Anne‐Marie Langevin
Rankless by CCL
2026